Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Procyon Advisors LLC

Procyon Advisors LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.1% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,257 shares of the medical equipment provider’s stock after acquiring an additional 248 shares during the period. Procyon Advisors LLC’s holdings in Intuitive Surgical were worth $3,071,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. One Wealth Management Investment & Advisory Services LLC raised its holdings in Intuitive Surgical by 3.4% during the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after purchasing an additional 23 shares in the last quarter. Daymark Wealth Partners LLC lifted its holdings in shares of Intuitive Surgical by 0.3% in the third quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock valued at $3,452,000 after buying an additional 24 shares during the period. Indiana Trust & Investment Management CO boosted its stake in Intuitive Surgical by 5.3% during the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after buying an additional 25 shares in the last quarter. Hoxton Planning & Management LLC raised its position in Intuitive Surgical by 4.9% in the second quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock worth $238,000 after acquiring an additional 25 shares in the last quarter. Finally, True North Advisors LLC increased its stake in Intuitive Surgical by 2.1% in the 3rd quarter. True North Advisors LLC now owns 1,232 shares of the medical equipment provider’s stock worth $605,000 after purchasing an additional 25 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 1,413 shares of the company’s stock in a transaction on Friday, July 26th. The shares were sold at an average price of $438.60, for a total transaction of $619,741.80. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,414,931.60. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Intuitive Surgical news, EVP Robert Desantis sold 1,413 shares of the company’s stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $438.60, for a total value of $619,741.80. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,414,931.60. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the transaction, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 53,120 shares of company stock valued at $25,528,753 over the last quarter. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $486.50 on Monday. The firm has a market cap of $172.56 billion, a price-to-earnings ratio of 87.51, a P/E/G ratio of 5.40 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $496.48. The firm’s 50-day simple moving average is $480.34 and its 200 day simple moving average is $435.19.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The firm had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. During the same period in the prior year, the company posted $1.18 earnings per share. The business’s revenue for the quarter was up 14.5% on a year-over-year basis. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have commented on ISRG shares. Evercore ISI raised their target price on shares of Intuitive Surgical from $410.00 to $475.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. Barclays increased their target price on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday. BTIG Research lifted their target price on Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. Finally, Morgan Stanley raised their target price on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. Six research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $458.35.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.